NeuroOne Medical Technologies Corporation
NMTC
$3.39
-$0.07-2.02%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -17.33% | -49.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -17.33% | -49.61% | |||
| Cost of Revenue | -5.22% | 16.49% | |||
| Gross Profit | -201.91% | -94.78% | |||
| SG&A Expenses | 1.80% | 5.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.35% | -35.32% | |||
| Operating Income | -23.05% | -24.52% | |||
| Income Before Tax | -45.05% | 11.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -45.05% | 11.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -45.05% | 11.20% | |||
| EBIT | -23.05% | -24.52% | |||
| EBITDA | -24.30% | -25.64% | |||
| EPS Basic | -43.41% | 11.70% | |||
| Normalized Basic EPS | -23.69% | -217.99% | |||
| EPS Diluted | -38.89% | 7.26% | |||
| Normalized Diluted EPS | -23.69% | -217.99% | |||
| Average Basic Shares Outstanding | 1.15% | 0.54% | |||
| Average Diluted Shares Outstanding | 1.15% | 0.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||